BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/8/2022 2:31:10 AM | Browse: 684 | Download: 1507
 |
Received |
|
2022-01-27 20:53 |
 |
Peer-Review Started |
|
2022-01-27 20:54 |
 |
First Decision by Editorial Office Director |
|
2022-04-18 00:23 |
 |
Return for Revision |
|
2022-04-18 00:23 |
 |
Revised |
|
2022-04-24 11:08 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-05-23 03:30 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-05-28 07:03 |
 |
Articles in Press |
|
2022-05-28 07:03 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2022-05-31 07:36 |
 |
Publish the Manuscript Online |
|
2022-06-08 02:31 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Basic Study |
| Article Title |
Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Arjun Jain, Kristof Bozovicar, Vidhi Mehrotra, Tomaz Bratkovic, Martin H Johnson and Ira Jha |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Arjun Jain, MPhil, PhD, Research Scientist, . jain_arjun@yahoo.com |
| Key Words |
Endothelin-1; Endothelin-traps; Diabetes; Heart failure; Chronic kidney disease; Novel therapeutic |
| Core Tip |
This study verified the specificity of endothelin (ET)-traps, which are an Fc-based fusion protein that acts as a potential therapeutic for various cET-1 related disorders, including diabetes and chronic kidney disease. ET-traps, unlike ET receptor antagonists, do not completely block the ET system and hence have minimal side effects. ET-traps would help save millions of lives around the world. |
| Publish Date |
2022-06-08 02:31 |
| Citation |
Jain A, Bozovicar K, Mehrotra V, Bratkovic T, Johnson MH, Jha I. Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders. World J Diabetes 2022; 13(6): 434-441 |
| URL |
https://www.wjgnet.com/1948-9358/full/v13/i6/434.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v13.i6.434 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.